Fintel reports that on October 14, 2025, Goldman Sachs initiated coverage of CVS Health (NYSE:CVS) with a Buy recommendation.
TipRanks on MSN
CVS Health price target raised to $92 from $84 at Truist
Truist analyst David MacDonald raised the firm’s price target on CVS Health (CVS) to $92 from $84 and keeps a Buy rating on ...
Save on concerts, games and more with the latest Vivid Seats coupons—get 10% off select purchases and find tickets for under ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback